Global Drugs for Schistosomiasis Competitive Landscape Professional Research Report 2025
Research Summary
Drugs for schistosomiasis are medications used to treat infections caused by parasitic worms of the Schistosoma genus. Praziquantel is the primary drug employed for treating all forms of schistosomiasis, a neglected tropical disease prevalent in areas with inadequate sanitation and freshwater exposure. Praziquantel targets the adult parasites, causing muscle paralysis and eventual death, allowing the body to eliminate them. The drug＇s effectiveness has made it a cornerstone of schistosomiasis control and elimination efforts. Given the disease＇s impact on millions of people, especially in Africa, praziquantel distribution and treatment campaigns are crucial components of public health strategies to combat schistosomiasis and reduce its health and socioeconomic burden.
According to DIResearch's in-depth investigation and research, the global Drugs for Schistosomiasis market size was valued at XX Million USD in 2024 and is projected to reach XX Million USD by 2032, with a CAGR of XX% (2025-2032). Notably, the China market has changed rapidly in the past few years. By 2024, China's market size is expected to be XX Million USD, representing approximately XX% of the global market share. By 2032, it is anticipated to grow further to XX Million USD, contributing XX% to the worldwide market share.
The major global manufacturers of Drugs for Schistosomiasis include Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Drugs for Schistosomiasis. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drugs for Schistosomiasis market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drugs for Schistosomiasis market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drugs for Schistosomiasis industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Drugs for Schistosomiasis Include:
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
Drugs for Schistosomiasis Product Segment Include:
Praziquantel
Oxamniquine
Others
Drugs for Schistosomiasis Product Application Include:
S. haematobium
S. mansoni
S. japonicum
S. mekongi
S. intercalatum
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Drugs for Schistosomiasis Industry PESTEL Analysis
Chapter 3: Global Drugs for Schistosomiasis Industry Porter’s Five Forces Analysis
Chapter 4: Global Drugs for Schistosomiasis Major Regional Market Size and Forecast Analysis
Chapter 5: Global Drugs for Schistosomiasis Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Passenger Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Drugs for Schistosomiasis Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Drugs for Schistosomiasis Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
- 1 Drugs for Schistosomiasis Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Drugs for Schistosomiasis Product by Type
- 1.2.1 Praziquantel
- 1.2.2 Oxamniquine
- 1.2.3 Others
- 1.3 Drugs for Schistosomiasis Product by Application
- 1.3.1 S. haematobium
- 1.3.2 S. mansoni
- 1.3.3 S. japonicum
- 1.3.4 S. mekongi
- 1.3.5 S. intercalatum
- 1.4 Global Drugs for Schistosomiasis Market Size Analysis (2020-2032)
- 1.5 Drugs for Schistosomiasis Market Development Status and Trends
- 1.5.1 Drugs for Schistosomiasis Industry Development Status Analysis
- 1.5.2 Drugs for Schistosomiasis Industry Development Trends Analysis
- 2 Drugs for Schistosomiasis Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Drugs for Schistosomiasis Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Drugs for Schistosomiasis Market Analysis by Regions
- 4.1 Drugs for Schistosomiasis Overall Market: 2024 VS 2025 VS 2032
- 4.2 Global Drugs for Schistosomiasis Revenue and Forecast Analysis (2020-2032)
- 4.2.1 Global Drugs for Schistosomiasis Revenue and Market Share by Region (2020-2025)
- 4.2.2 Global Drugs for Schistosomiasis Revenue Forecast by Region (2026-2032)
- 5 Global Drugs for Schistosomiasis Market Size by Type and Application
- 5.1 Global Drugs for Schistosomiasis Market Size by Type (2020-2032)
- 5.2 Global Drugs for Schistosomiasis Market Size by Application (2020-2032)
- 6 North America
- 6.1 North America Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
- 6.2 North America Key Manufacturers Analysis
- 6.3 North America Drugs for Schistosomiasis Market Size by Type
- 6.4 North America Drugs for Schistosomiasis Market Size by Application
- 6.5 North America Drugs for Schistosomiasis Market Size by Country
- 6.5.1 US
- 6.5.2 Canada
- 7 Europe
- 7.1 Europe Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
- 7.2 Europe Key Manufacturers Analysis
- 7.3 Europe Drugs for Schistosomiasis Market Size by Type
- 7.4 Europe Drugs for Schistosomiasis Market Size by Application
- 7.5 Europe Drugs for Schistosomiasis Market Size by Country
- 7.5.1 Germany
- 7.5.2 France
- 7.5.3 United Kingdom
- 7.5.4 Italy
- 7.5.5 Spain
- 7.5.6 Benelux
- 8 China
- 8.1 China Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
- 8.2 China Key Manufacturers Analysis
- 8.3 China Drugs for Schistosomiasis Market Size by Type
- 8.4 China Drugs for Schistosomiasis Market Size by Application
- 9 APAC (excl. China)
- 9.1 APAC (excl. China) Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
- 9.2 APAC (excl. China) Key Manufacturers Analysis
- 9.3 APAC (excl. China) Drugs for Schistosomiasis Market Size by Type
- 9.4 APAC (excl. China) Drugs for Schistosomiasis Market Size by Application
- 9.5 APAC (excl. China) Drugs for Schistosomiasis Market Size by Country
- 9.5.1 Japan
- 9.5.2 South Korea
- 9.5.3 India
- 9.5.4 Australia
- 9.5.5 Southeast Asia
- 10 Latin America
- 10.1 Latin America Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
- 10.2 Latin America Key Manufacturers Analysis
- 10.3 Latin America Drugs for Schistosomiasis Market Size by Type
- 10.4 Latin America Drugs for Schistosomiasis Market Size by Application
- 10.5 Latin America Drugs for Schistosomiasis Market Size by Country
- 10.5.1 Mexico
- 10.5.2 Brazil
- 11 Middle East & Africa
- 11.1 Middle East & Africa Drugs for Schistosomiasis Market Size and Growth Rate Analysis (2020-2032)
- 11.2 Middle East & Africa Key Manufacturers Analysis
- 11.3 Middle East & Africa Drugs for Schistosomiasis Market Size by Type
- 11.4 Middle East & Africa Drugs for Schistosomiasis Market Size by Application
- 11.5 Middle East & Africa Drugs for Schistosomiasis Market Size by Country
- 11.5.1 Saudi Arabia
- 11.5.2 South Africa
- 12 Competition by Manufacturers
- 12.1 Global Drugs for Schistosomiasis Market Revenue by Key Manufacturers (2021-2025)
- 12.2 Drugs for Schistosomiasis Competitive Landscape Analysis and Market Dynamic
- 12.2.1 Drugs for Schistosomiasis Competitive Landscape Analysis
- 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales
- 12.2.3 Market Dynamic
- 13 Key Companies Analysis
- 13.1 Shin Poong
- 13.1.1 Shin Poong Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.1.2 Shin Poong Drugs for Schistosomiasis Product Portfolio
- 13.1.3 Shin Poong Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.2 Merck
- 13.2.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.2.2 Merck Drugs for Schistosomiasis Product Portfolio
- 13.2.3 Merck Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.3 Bayer
- 13.3.1 Bayer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.3.2 Bayer Drugs for Schistosomiasis Product Portfolio
- 13.3.3 Bayer Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.4 EIPICO
- 13.4.1 EIPICO Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.4.2 EIPICO Drugs for Schistosomiasis Product Portfolio
- 13.4.3 EIPICO Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.5 Chandra Bhagat Pharma
- 13.5.1 Chandra Bhagat Pharma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.5.2 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Portfolio
- 13.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 13.6 Taj Pharmaceuticals
- 13.6.1 Taj Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 13.6.2 Taj Pharmaceuticals Drugs for Schistosomiasis Product Portfolio
- 13.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 14 Industry Chain Analysis
- 14.1 Drugs for Schistosomiasis Industry Chain Analysis
- 14.2 Drugs for Schistosomiasis Industry Raw Material and Suppliers Analysis
- 14.2.1 Drugs for Schistosomiasis Key Raw Material Supply Analysis
- 14.2.2 Raw Material Suppliers and Contact Information
- 14.3 Drugs for Schistosomiasis Typical Downstream Customers
- 14.4 Drugs for Schistosomiasis Sales Channel Analysis
- 15 Research Findings and Conclusion
- 16 Methodology and Data Source
- 16.1 Methodology/Research Approach
- 16.2 Research Scope
- 16.3 Benchmarks and Assumptions
- 16.4 Date Source
- 16.4.1 Primary Sources
- 16.4.2 Secondary Sources
- 16.5 Data Cross Validation
- 16.6 Disclaimer
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook